Skip to main content

Table 2 Univariate analysis of DFS and OS for diabetic NSCLC patients

From: Prognostic value of metformin for non-small cell lung cancer patients with diabetes

  DFS OS
  p value HR 95% CI p value HR 95% CI
Age (years) 0.511 1.563 1.032–1.877 0.104 1.106 0.948–1.753
 < 65       
 ≥ 65       
Gender 0.210 0.874 0.703–1.489 0.109 0.748 0.720–1.310
 Female       
 Male       
Smoking status 0.355 1.575 0.998–1.981 0.647 1.171 0.598–1.301
 Non-smoker       
 Smoker       
Histology 0.879 0.877 0.643–1.637 0.511 0.974 0.544–1.710
 Squamous       
 Non-squamous       
Tumor location 0.105 0.987 0.774–1.021 0.314 1.014 0.784–1.879
 Left       
 Right       
Stage 0.001 1.878 1.170–2.474 0.037 1.440 1.110–1.901
 I       
 II       
 III       
Tumor recurrence 0.513 1.547 1.104–1.987 0.010 1.754 1.245–2.014
 No       
 Yes       
Metformin use 0.010 0.69 0.387–0.947 0.005 0.548 0.401–0.755
 No       
 Yes